Gold rods used to ‘break cancer’s legs’

June 28, 2017
Research and Development Cancer, Georgia Tech, nanorods

A study emerging from Georgia Tech has found a new way of stopping metastasising cancer’s spread through the body. The …

hack

MSD struck in second global cyber attack

June 28, 2017
Medical Communications, Research and Development Cyber attack, MSD

Following the recent and heavily-publicised ransomware attack which hit the NHS in the UK and almost 100 other countries, the …

microneedle-patch4004

Revolutionary patch could offer alternative to flu injections

June 28, 2017
Research and Development flu, flu vaccine, patch delivery

A patch developed by a team at the Georgia Institute of Technology alongside Emory University has found that it is …

fdaoutsideweb

FDA weighs in to improve generic competition

June 27, 2017
Medical Communications, Sales and Marketing FDA, generic drugs, pricing debate

Since Scott Gottlieb was appointed Commissioner, the FDA has been on a marked push to tackle two areas: drug pricing …

Novo Nordisk’s diabetes drug recommended for expanded indication in Europe

June 27, 2017
Research and Development, Sales and Marketing CHMP, EMA, EU, Novo Nordisk, Victoza

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has given its recommendation to expand the indication of Novo …

sanofi_regeneron

New potential blockbuster RA treatment enters European market

June 27, 2017
Sales and Marketing AbbVie, Humria, Kevzara, Regeneron, Sanofi

The world’s biggest selling drug, AbbVie’s Humira with $16 billion in sales last year, has a new rival in the …

kress

Biogen appoint new Head of Global Therapeutic Operations

June 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen, Jean-Paul Kress

Biogen announced that Jean-Paul Kress has been appointed to the position of Executive Vice President and President, International, and Head …

novartis_side_building

UK launch of two Novartis biosimilars could cut NHS costs

June 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Erelzi, Novartis, Rixathon, Sandoz, biosimilar, etanercept, rituximab

Sandoz, a division of Swiss pharma giant Novartis, has revealed that two of its biosimilars – Rixathon (biosimilar rituximab) and …

filing_cabinet

Number of patients at risk from NHS mail mistake revealed

June 27, 2017
Manufacturing and Production, Medical Communications Department of Health, Jeremy Hunt, NHS, NHS England

According to the patient records that have been examined so far, at least 1,700 may have been put at risk …

thumbs_up

Duchenne drug made available to UK patients early

June 27, 2017
Manufacturing and Production, Sales and Marketing Duchenne Muscular Dystrophy, Raxone

UK patients will be given access to Santhera Pharmaceutical’s Duchene Muscular Dystrophy (DMD) drug, Raxone (idebenone), through the Early Access …

pills-384846_960_720

Therapy able to block both opioid high and withdrawal

June 26, 2017
Manufacturing and Production, Research and Development Camurus, buprenorphine

A study into an injectable form of buprenorphine treatment for opioid abuse has found that the formulation is able to …

shutterstock_57369385

Drug Combinations and Emerging Interactions

June 26, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug combinations, drug resistance, feature

Pamela Yeh, Assistant Professor at the Department of Ecology and Evolutionary Biology, University of California, Los Angeles, discusses how drug …

Humira set to face new European biosimilar rival

June 26, 2017
Sales and Marketing CHMP, EMA, Samsung Bioepis

A position opinion from the EMA for Samsung Bioepis’ biosimilar of Humira looks set to unleash a second rival to …

roche

Roche haemophilia therapy cuts bleed rate by 87%

June 26, 2017
Research and Development, Sales and Marketing Roche, haemophilia

Roche has revealed new data on its investigational haemophilia therapy ACE910 (emicizumab) which shows an 87% reduction in bleed rate …

nhs_parliament_2_4

Public dissatisfaction with NHS found to be growing, says BMA

June 26, 2017
Medical Communications, Sales and Marketing BMA, NHS

The British Medical Association has revealed that a poll, conducted by British doctors, shows that levels of public dissatisfaction with …

novo_nordisk_flag

Promising Phase 2 obesity data for Novo’s diabetes drug

June 26, 2017
Research and Development, Sales and Marketing Novo Nordisk

Novo Nordisk is hopeful about the prospects of its diabetes drug semaglutide as a treatment for obesity after it produced …

Astellas receives further year suspension from ABPI

June 26, 2017
Medical Communications, Sales and Marketing ABPI, Astellas

The Association of the British Pharmaceutical Industry (ABPI) has announced that it has taken the unusual step of extending the …

Woodley Equipment Attending Outsourcing in Clinical Trials UK & Ireland 2017

June 23, 2017

Woodley Equipment is attending Outsourcing in Clinical Trials UK and Ireland Conference taking place at the Royal Garden Hotel, London …

Pfizer’s biosimilar gets a second knock-back from FDA

June 23, 2017
Medical Communications, Sales and Marketing Amgen, Epogen, FDA, Pfizer

Pfizer has been dealt a stinging blow by the FDA, after it received a second complete response letter from the …

The Gateway to Local Adoption Series

Latest content